High prevalence of BK polyomavirus sequences in human papillomavirus-16-positive precancerous cervical lesions

J Med Virol. 2011 Oct;83(10):1770-6. doi: 10.1002/jmv.22184.

Abstract

High- and low-grade cervical lesions were analyzed for the presence of polyomavirus (PYV) and human papillomavirus (HPV) sequences. In precancerous cervical lesions, the overall prevalence of PYV sequences was 44% (41/93). Specifically, among the PYV-positive samples, 83% (34/41) tested positive for BK polyomavirus (BKV) sequences, whereas 17% (7/41) were positive for JC-virus. None of the samples were positive for simian virus 40. The presence of BKV DNA in high-grade squamous intraepithelial lesions was confirmed by in situ PCR. BKV sequences were detected more frequently in high-grade squamous intraepithelial lesions, together with the genotype HPV-16. The association of BKV with precancerous cervical lesions suggests that this polyomavirus participates with HPV-16 in the cell transformation process. Alternatively, BKV might multiply better in HPV-16-positive cells from precancerous cervical lesions than in HPV-16-negative cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • BK Virus / genetics
  • BK Virus / isolation & purification*
  • Cervix Uteri / pathology
  • Cervix Uteri / virology
  • DNA, Viral / blood
  • Female
  • Human papillomavirus 16* / genetics
  • Human papillomavirus 16* / isolation & purification
  • Human papillomavirus 18 / genetics
  • Human papillomavirus 18 / isolation & purification
  • Human papillomavirus 31 / genetics
  • Human papillomavirus 31 / isolation & purification
  • Humans
  • JC Virus / genetics
  • JC Virus / isolation & purification
  • Middle Aged
  • Oncogene Proteins, Viral
  • Papillomavirus Infections / virology*
  • Precancerous Conditions / virology*
  • Simian virus 40 / genetics
  • Simian virus 40 / isolation & purification
  • Uterine Cervical Diseases / virology*
  • Uterine Cervical Dysplasia / virology*

Substances

  • DNA, Viral
  • Oncogene Proteins, Viral